Avantium
2000
FOUNDED
PUBLIC
STATUS
101-200
EMPLOYEES
AVTX
STOCK SYMBOL
2
INVESTMENTS
$2.77
SHARE PRICE
(As of Friday Closing)
Description
Avantium NV along with its subsidiaries is engaged in developing and commercializing next generation bio-based plastics and chemicals based on its technological capabilities in advanced catalysis research & development. The company operates through Catalysis and Renewable Chemistries segments. It generates majority revenue from Catalysis segment.
Primary Industry
Other Commercial Services
Other Industries
Industrial Chemicals
Stock Exchange
AMS
Primary Office
- Zekeringstraat 29
- 1014 BV Amsterdam
- Netherlands
+31 020 000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Avantium’s full profile, request a free trial.
Avantium Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $2.00 - $5.58 | $71.7M | $2.60 | -$3.30 | 10.8K | 25.8M |
Avantium Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | (25,534) | (27,073) | 256,693 | |
| Revenue | 11,479 | 13,315 | 14,268 | 11,605 |
| EBITDA | (80,209) | (78,562) | (17,236) | (4,406) |
| Net Income | (84,951) | (80,691) | (18,901) | 42,185 |
| Total Assets | 115,177 | 130,320 | 202,523 | 90,613 |
| Total Debt | 12,680 | 27,810 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Avantium Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Avantium‘s full profile, request access.
Request full access to PitchBookAvantium Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00 0000000000 0000 | Venture Capital-Backed | Woburn, MA | 00 | 0000 | 00000000 |
Avantium Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 00000 | 10-Jan-2017 | 000000000000000000 | Industrial Chemicals | 000 000 0000 | |
| Synvina | 07-Oct-2016 | Joint Venture | Industrial Chemicals | 000 000 0000 |
Avantium Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Avantium‘s full profile, request access.
Request full access to PitchBookAvantium Executive Team (13)
3 Former Executives
You’re viewing 5 of 13 executives. Get the full list »Avantium Board Members (10)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Denis Lucquin | Sofinnova Partners | Board Member | 000 0000 | |
| Gabrielle Reijnen | Self | Board Member | 000 0000 | |
| Jonathan Wolfson JD | Self | Board Member | 000 0000 | |
| Michiel Boersma Ph.D | Self | Chairman | 000 0000 |
6 Former Board Members
You’re viewing 4 of 10 board members. Get the full list »